BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 33480694)

  • 1. In Silico Analysis Revealed a Unique Binding but Ineffective Mode of Amantadine to Influenza Virus B M2 Channel.
    Zhang Y; Zheng QC
    J Phys Chem Lett; 2021 Feb; 12(4):1169-1174. PubMed ID: 33480694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.
    Ohigashi Y; Ma C; Jing X; Balannick V; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18775-9. PubMed ID: 19841275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the proton conductance and drug resistance of BM2 channel through molecular dynamics simulations and free energy calculations at different pH conditions.
    Zhang Y; Shen H; Zhang M; Li G
    J Phys Chem B; 2013 Jan; 117(4):982-8. PubMed ID: 23286443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus.
    Ma C; Soto CS; Ohigashi Y; Taylor A; Bournas V; Glawe B; Udo MK; Degrado WF; Lamb RA; Pinto LH
    J Biol Chem; 2008 Jun; 283(23):15921-31. PubMed ID: 18408016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oligomeric state of the active BM2 ion channel protein of influenza B virus.
    Balannik V; Lamb RA; Pinto LH
    J Biol Chem; 2008 Feb; 283(8):4895-904. PubMed ID: 18073201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flu channel drug resistance: a tale of two sites.
    Pielak RM; Chou JJ
    Protein Cell; 2010 Mar; 1(3):246-58. PubMed ID: 21203971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structure, Function, and Pathobiology of the Influenza A and B Virus Ion Channels.
    Lamb RA
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31988204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protonation equilibria and pore-opening structure of the dual-histidine influenza B virus M2 transmembrane proton channel from solid-state NMR.
    Williams JK; Shcherbakov AA; Wang J; Hong M
    J Biol Chem; 2017 Oct; 292(43):17876-17884. PubMed ID: 28893910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why amantadine loses its function in influenza m2 mutants: MD simulations.
    Laohpongspaisan C; Rungrotmongkol T; Intharathep P; Malaisree M; Decha P; Aruksakunwong O; Sompornpisut P; Hannongbua S
    J Chem Inf Model; 2009 Apr; 49(4):847-52. PubMed ID: 19281265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine.
    Yi M; Cross TA; Zhou HX
    J Phys Chem B; 2008 Jul; 112(27):7977-9. PubMed ID: 18476738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulations of the BM2 proton channel transmembrane domain from influenza virus B.
    Rouse SL; Carpenter T; Stansfeld PJ; Sansom MS
    Biochemistry; 2009 Oct; 48(42):9949-51. PubMed ID: 19780586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What are the effects of the serine triad on proton conduction of an influenza B M2 channel? An investigation by molecular dynamics simulations.
    Zhang Y; Zheng QC
    Phys Chem Chem Phys; 2019 Apr; 21(17):8820-8826. PubMed ID: 30968902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural investigation of rimantadine inhibition of the AM2-BM2 chimera channel of influenza viruses.
    Pielak RM; Oxenoid K; Chou JJ
    Structure; 2011 Nov; 19(11):1655-63. PubMed ID: 22078564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.